Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic SyndromesElisabetta Sauta, Matteo Giovanni Della Porta, Niccolò Bolli et al.|Journal of Clinical Oncology|2023Cited by 109
Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in HematologySaverio D’Amico, Matteo Giovanni Della Porta, Daniele Dall’Olio et al.|JCO Clinical Cancer Informatics|2023Cited by 86
Clinical relevance of clonal hematopoiesis in persons aged ≥80 yearsMarianna Rossi, Gastone Castellani, Manja Meggendorfer et al.|Blood|2021Cited by 72
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort studyGiulia Maggioni, Uwe Platzbecker, Matteo Bersanelli et al.|The Lancet Haematology|2022Cited by 34
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic SyndromesMatteo Zampini, Matteo Giovanni Della Porta, Elena Riva et al.|Journal of Clinical Oncology|2025Cited by 13